Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up

Acta Psychiatrica Scandinavica
W P HornungH Schulze Mönking

Abstract

Within a controlled prospective intervention study, schizophrenic outpatients randomly assigned to four treatment groups and one control group were assessed with regard to collaboration with drug treatment. In total, 39.3% of 84 regular attenders of the psychoeducational training programme and 26.6% of 64 control patients reported having persuaded their psychiatrists to modify their medication prescriptions. A total of 8.3% and 7.8%, respectively, modified their medication on their own initiative, although with subsequent approval by the psychiatrist, and 20.2% and 15.6%, respectively, modified their medication after consulting their psychiatrist. With regard to medication management, the groups did not differ either at post-treatment or at follow-up. At follow-up, regular attenders showed a reduced fear of side-effects, increased confidence in their medication and stable confidence in their physician. Among the control subjects, confidence in the medication and in their physician declined, and fear of side-effects increased. Psychoeducational training therefore led to an optimization of patients' attitudes toward treatment, but not to changes in medication management.

References

Feb 1, 1977·Archives of General Psychiatry·J S Strauss, W T Carpenter
May 1, 1976·Social Science & Medicine·D E Hayes-Bautista
Sep 1, 1975·Journal of Medical Ethics·D G Grahame-Smith
Nov 1, 1992·The American Journal of Psychiatry·T A EckmanJ Mintz
Feb 1, 1990·Journal of Clinical Psychopharmacology·T A EckmanK E Blair
Apr 1, 1986·The American Journal of Psychiatry·R P LibermanC J Wallace
Jun 1, 1981·The American Journal of Psychiatry·I M Lesser, C T Friedmann
Mar 1, 1983·Culture, Medicine and Psychiatry·J A TrostleI S Susser
Feb 10, 1996·BMJ : British Medical Journal·R KempA David
Feb 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·J M AtkinsonJ P Harper
Dec 1, 1996·Patient Education and Counseling·W P HornungG Buchkremer

❮ Previous
Next ❯

Citations

Aug 28, 2007·Social Psychiatry and Psychiatric Epidemiology·Ingrid SibitzHeinz Katschnig
Feb 12, 2008·Social Psychiatry and Psychiatric Epidemiology·Michael LindenHans-Peter Hundemer
Feb 19, 2004·Epidemiologia e psichiatria sociale·Michela Nosè, Corrado Barbui
Nov 7, 2000·PharmacoEconomics·E Lindström, K Bingefors
Sep 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Michela NoséMichele Tansella
May 20, 2005·Archives of Psychiatric Nursing·Yoriko KozukiKaren Schepp
Dec 22, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·Ingrid SibitzHeinz Katschnig
May 13, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·E BarkhofL de Haan
Jan 1, 2007·International Journal of Psychiatry in Clinical Practice·Meera NarasimhanPrakash Masand
Jun 19, 2001·The Cochrane Database of Systematic Reviews·S Reda, S Makhoul
Apr 20, 2002·Addiction·Elizabeth M Hill, Krista Chow
Apr 10, 2015·The Cochrane Database of Systematic Reviews·Sai ZhaoMahesh B Jayaram
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Robby NieuwlaatR Brian Haynes
Apr 22, 2008·The Cochrane Database of Systematic Reviews·R B HaynesX Yao
Oct 17, 2006·The Journal of Nervous and Mental Disease·Bernd PuschnerThomas Becker
Aug 12, 1999·Acta Psychiatrica Scandinavica·K SutherbyS Wright
Jan 13, 2006·Psychiatry and Clinical Neurosciences·Toshinori Kitamura
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Jun XiaMadhvi R Belgamwar
Jan 19, 2002·Journal of Clinical Psychopharmacology·Thomas L PattersonDilip V Jeste
Aug 16, 2003·Journal of Clinical Psychopharmacology·Christian R DolderDilip V Jeste
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Richard MorrissJames P McCarthy
Apr 15, 2015·The Cochrane Database of Systematic Reviews·Lucy A BuckleyClive E Adams
May 29, 1999·British Journal of Nursing : BJN·M Coffey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.